News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,493 Results
Type
Article (85271)
Company Profile (622)
Press Release (738600)
Section
Business (231860)
Career Advice (4090)
Deals (39622)
Drug Delivery (106)
Drug Development (90431)
Employer Resources (192)
FDA (17889)
Job Trends (17246)
News (394629)
Policy (39585)
Tag
Academia (2973)
Africa (1263)
Alliances (56342)
Alzheimer's disease (1248)
Approvals (17798)
Arizona (210)
Artificial intelligence (86)
Asia (49003)
Australia (8618)
Bankruptcy (392)
Best Places to Work (12258)
Biotechnology (438)
C2C Services and Suppliers (95111)
California (2025)
Canada (947)
Cancer (543)
Career advice (3497)
Cell therapy (142)
China (157)
Clinical research (70443)
Collaboration (155)
Colorado (83)
Compensation (82)
Connecticut (84)
COVID-19 (2754)
Cystic fibrosis (78)
Data (313)
Diabetes (92)
Diagnostics (6500)
Drug pricing (84)
Earnings (93522)
Employer resources (162)
Europe (112022)
Events (125005)
Executive appointments (160)
FDA (18121)
Florida (273)
Funding (155)
Gene therapy (108)
GLP-1 (620)
Government (5009)
Healthcare (20653)
Hotbed/Location (534575)
Illinois (322)
Indiana (161)
Infectious disease (2785)
Inflammatory bowel disease (102)
Interviews (805)
IPO (17492)
Job creations (5172)
Job search strategy (2849)
Kansas (100)
Layoffs (467)
Legal (10013)
Lung cancer (126)
Manufacturing (101)
Maryland (433)
Massachusetts (1720)
Medical device (14264)
Medtech (14269)
Mergers & acquisitions (21962)
Metabolic disorders (297)
Michigan (137)
Minnesota (236)
Neuroscience (1415)
New Jersey (617)
New York (623)
NextGen Class of 2024 (7622)
Non-profit (5053)
North Carolina (703)
Northern California (842)
Obesity (178)
Ohio (110)
Opinion (234)
Patents (78)
Pennsylvania (596)
People (63723)
Pharmaceutical (119)
Phase I (21629)
Phase II (30583)
Phase III (23108)
Pipeline (111)
Podcasts (76)
Postmarket research (3532)
Preclinical (9772)
Press Release (72)
Rare diseases (142)
Real estate (7362)
Recruiting (72)
Regulatory (25601)
Research institute (2633)
Resumes & cover letters (645)
South America (1641)
Southern California (777)
Startups (4272)
Texas (267)
United States (9385)
Vaccines (567)
Washington State (282)
Weight loss (170)
Date
Today (194)
Last 7 days (719)
Last 30 days (2542)
Last 365 days (40025)
2024 (28155)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,493 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
M&A
Roivant Deals Again, Sending Dermavant to Organon in Sale Worth Up to $1.2B
The sale of Dermavant clears the way for Roivant to focus on autoimmune-focused Immunovant and a slate of upcoming pivotal trials.
September 18, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Laurentis signs MOU with Colibri to pursue isotopes irradiation services
September 18, 2024
·
3 min read
Press Releases
Psyence Group’s NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
September 18, 2024
·
7 min read
Press Releases
Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI
September 18, 2024
·
7 min read
Lung cancer
Despite Win Over Keytruda, Summit’s NSCLC Bispecific Still Has Something to Prove
Summit Therapeutics’ ivonescimab has the potential to challenge Merck’s blockbuster checkpoint inhibitor in non-small cell lung cancer, but experts stress the need for diverse and overall survival data.
September 18, 2024
·
5 min read
·
Kate Goodwin
Press Releases
PictorLabs Raises $30 Million in Series B Funding to Accelerate AI-Powered Virtual Staining Technology
September 18, 2024
·
4 min read
Press Releases
Specialist CRO Welcomes Dr Juan Gabriel Ovalles Bonilla as Medical Rheumatology Lead
September 18, 2024
·
1 min read
Press Releases
Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society
September 18, 2024
·
5 min read
Press Releases
BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference
September 18, 2024
·
7 min read
Press Releases
Progressive Medical Collaborating with MellingMedical to Offer Products Through the Federal Health System
September 18, 2024
·
3 min read
1 of 82,450
Next
